LOXO
E561034
LOXO was the stock ticker symbol for Loxo Oncology, a biopharmaceutical company focused on developing targeted cancer therapies before its acquisition.
All labels observed (2)
| Label | Occurrences |
|---|---|
| LOXO canonical | 2 |
| Loxo Oncology | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T6003719 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: LOXO Context triple: [Loxo Oncology, tickerSymbolBeforeAcquisition, LOXO]
-
A.
The LOX
The LOX is an American hip hop group from Yonkers, New York, known for its gritty street lyrics and members Jadakiss, Styles P, and Sheek Louch.
-
B.
Inflectra
Inflectra is a biosimilar monoclonal antibody to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
-
C.
Loëx
Loëx is a small locality within the municipality of Bernex in the canton of Geneva, Switzerland.
-
D.
Morgex
Morgex is a small Alpine town and comune in Italy’s Aosta Valley, known for its mountain scenery and production of high-altitude white wines.
-
E.
Versonnex
Versonnex is a small commune in the Ain department of eastern France, located near the Swiss border in the Pays de Gex region.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: LOXO Target entity description: LOXO was the stock ticker symbol for Loxo Oncology, a biopharmaceutical company focused on developing targeted cancer therapies before its acquisition.
-
A.
The LOX
The LOX is an American hip hop group from Yonkers, New York, known for its gritty street lyrics and members Jadakiss, Styles P, and Sheek Louch.
-
B.
Inflectra
Inflectra is a biosimilar monoclonal antibody to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
-
C.
Loëx
Loëx is a small locality within the municipality of Bernex in the canton of Geneva, Switzerland.
-
D.
Morgex
Morgex is a small Alpine town and comune in Italy’s Aosta Valley, known for its mountain scenery and production of high-altitude white wines.
-
E.
Versonnex
Versonnex is a small commune in the Ain department of eastern France, located near the Swiss border in the Pays de Gex region.
- F. None of above. chosen
Statements (27)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
cancer drug ⓘ public company ⓘ stock ticker symbol ⓘ |
| acquiredBy | Eli Lilly and Company ⓘ |
| acquisitionAnnouncedOn | 2019-01-07 ⓘ |
| acquisitionCompletedIn | 2019 ⓘ |
| acquisitionValueUSD | 8000000000 ⓘ |
| businessModel | development of small molecule inhibitors ⓘ |
| country |
United States
ⓘ
linked to:
United States of America
|
| focus |
oncology
ⓘ
targeted cancer therapies ⓘ |
| foundedBy | Joshua Bilenker ⓘ |
| headquartersLocation | Stamford, Connecticut ⓘ |
| indication |
RET-altered cancers
ⓘ
solid tumors with NTRK gene fusions ⓘ |
| industry | biotechnology ⓘ |
| notableDrugCandidate |
larotrectinib
ⓘ
selpercatinib ⓘ |
| parentCompanyAfterAcquisition | Eli Lilly and Company ⓘ |
| represents |
Loxo Oncology
ⓘ
linked to:
LOXO
|
| researchArea |
genomically defined cancers
ⓘ
precision oncology ⓘ |
| stockExchange | NASDAQ ⓘ |
| target |
RET kinase
ⓘ
TRK fusion proteins ⓘ |
| tickerSymbol | LOXO ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: LOXO Description of subject: LOXO was the stock ticker symbol for Loxo Oncology, a biopharmaceutical company focused on developing targeted cancer therapies before its acquisition.
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.